A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Artios Pharma Ltd
Artios Pharma Ltd
National Cancer Institute (NCI)
Frontier Medicines Corporation
Boehringer Ingelheim
Bristol-Myers Squibb
Genmab
Revolution Medicines, Inc.
Massachusetts General Hospital
PMV Pharmaceuticals, Inc
M.D. Anderson Cancer Center
Novartis
M.D. Anderson Cancer Center
HonorHealth Research Institute
National Institutes of Health Clinical Center (CC)
Verastem, Inc.
M.D. Anderson Cancer Center
BioNTech SE
Akeso
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Icahn School of Medicine at Mount Sinai
Institut du Cancer de Montpellier - Val d'Aurelle
Eisai Inc.
Ipsen
Second Affiliated Hospital, School of Medicine, Zhejiang University
Blue Earth Diagnostics
Sichuan Enray Pharmaceutical Sciences Company
Children's Oncology Group
A2 Biotherapeutics Inc.
AstraZeneca
Merus B.V.
Arvinas Inc.
Icahn School of Medicine at Mount Sinai
Essen Biotech
Essen Biotech
Novartis
Betta Pharmaceuticals Co., Ltd.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Revolution Medicines, Inc.
Luye Pharma Group Ltd.
Institut du Cancer de Montpellier - Val d'Aurelle
GlaxoSmithKline
Syndax Pharmaceuticals
Chimeric Therapeutics
Auricula Biosciences Inc.
City of Hope Medical Center
One-carbon Therapeutics AB
IDEAYA Biosciences
Bold Therapeutics, Inc.
M.D. Anderson Cancer Center